ProShares UltraShort Nasdaq Biotechnology (BIS)

NASDAQ: BIS · Real-Time Price · USD
14.62
-0.25 (-1.71%)
Jun 25, 2026, 4:00 PM EDT - Market closed
Assets$2.53M
Expense Ratio0.95%
PE Ration/a
Shares Out165,519
Dividend (ttm)$0.79
Dividend Yield5.39%
Ex-Dividend DateJun 24, 2026
Payout FrequencyQuarterly
Payout Ration/a
Volume4,231
Open14.95
Previous Close14.87
Day's Range14.56 - 14.95
52-Week Low14.56
52-Week High35.69
Beta-1.20
Holdings6
Inception DateApr 8, 2010

About BIS

Fund Home Page

The ProShares UltraShort Nasdaq Biotechnology (BIS) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index. The fund provides -2x exposure to a market-cap-weighted index of biotechnology and pharmaceutical companies listed on the NASDAQ. BIS was launched on Apr 8, 2010 and is issued by ProShares.

Asset Class Equity
Category Trading--Inverse Equity
Stock Exchange NASDAQ
Ticker Symbol BIS
ETF Provider ProShares
Index Tracked NASDAQ / Biotechnology

Top Holdings

-200.57% of assets
NameSymbolWeight
NET OTHER ASSETS (LIABILITIES)n/a
NASDAQ BIO INDEX SWAP BNP PARIBASn/a-17.79%
NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALEn/a-34.61%
NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AGn/a-38.26%
NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NAn/a-38.99%
NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NAn/a-70.92%
View More Holdings

Dividend History

Ex-DividendAmountPay Date
Jun 24, 2026$0.1366Jun 30, 2026
Mar 25, 2026$0.13714Mar 31, 2026
Dec 24, 2025$0.20514Dec 31, 2025
Sep 24, 2025$0.30854Sep 30, 2025
Jun 25, 2025$0.2161Jul 1, 2025
Mar 26, 2025$0.2651Apr 1, 2025
Full Dividend History

Performance

BIS had a total return of -56.24% in the past year, including dividends. Since the fund's inception, the average annual return has been -32.47%.